Publications
5803 Results
- Journal / Conference
- Journal of Thoracic Oncology Mar;20(3):383-394
- Year
- 2025
- Research Committee(s)
- Lung
- PMID
- PMID39505259
- Study Number(s)
- S1929
Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929
- Journal / Conference
- Journal of Clinical Oncology Apr 10;43(11):1348-1357
- Year
- 2025
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID39761503
- PMC
- PMC11975499
- Study Number(s)
- S1613
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patient with RAS/BRAF wild-type, HER2-positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase 2 Trial
- Journal / Conference
- Clinical Trials 2025 Jun;22(3):361-366. doi: 10.1177/17407745241304065. Epub 2025 Jan 15.
- Year
- 2025
- Research Committee(s)
- Leukemia
- Study Number(s)
- MYELOMATCH
Evaluating the impact of stratification on the power and cross-arm balance of randomized Phase 2 clinical trials
- Journal / Conference
- Journal of Medical Internet Research vol. 27 | e66821
- Year
- 2025
- Research Committee(s)
- Breast
- PMID
- 40053790
- Study Number(s)
- S0307
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study
- Journal / Conference
- JAMA Network Open Mar 3;8(3):e250778
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID40080017
- PMC
- PMC11907310
Health Care Contact Days for Older Adults Enrolled in Cancer Clinical Trials
- Journal / Conference
- JNCI Monograph Mar 1;2025(68):3-9
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID39989044
- PMC
- PMC11848029
When to Adjust for Multiplicity in Cancer Clinical Trials
- Journal / Conference
- Cancer Control Jan-Dec:32:10732748251344469
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID40384469
- PMC
- PMC12089715
- Study Number(s)
- S1912CD
Addressing Challenges in Research Aimed at Reducing Financial Toxicity Among Cancer Patients and Caregivers: An Example From the CREDIT Study (SWOG S1912CD)
- Journal / Conference
- ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), oral
- Year
- 2025
- Research Committee(s)
- Breast
- Study Number(s)
- S1416
Concordance Between Liquid and Tissue-Based Assessment of Somatic Homologous Recombination Deficiency (HRD) in Triple-Negative Breast Cancer (TNBC) from SWOG S1416 Trial
- Journal / Conference
- JNCI Monographs Mar 1;2025(68):65-72
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID39989039
- PMC
- PMC11848034
- Study Number(s)
- S1415CD
Intracluster Correlation Coefficients from Cluster Randomized Trials Conducted within the NCI Community Oncology Research Program (NCORP)
- Journal / Conference
- Leukemia
- Year
- 2025
- Research Committee(s)
- Leukemia
- PMID
- PMID39870766
- Study Number(s)
- S1203